Medical Condition News

RSS

Transcendental Meditation lowers rates of heart attack, stroke, and death

Patients with coronary heart disease who practiced the stress-reducing Transcendental Meditation® technique had nearly 50 percent lower rates of heart attack, stroke, and death compared to nonmeditating controls, according to the results of a first-ever study presented during the annual meeting of the American Heart Association in Orlando, Fla., on Nov.16, 2009.

16 Nov 2009

Fetal exposure to phthalates has the potential to alter masculine brain development: Study

A study of 145 preschool children reports, for the first time, that when the concentrations of two common phthalates in mothers' prenatal urine are elevated their sons are less likely to play with male-typical toys and games, such as trucks and play fighting.

16 Nov 2009

RecordAF presents results of recently diagnosed and treated patients with atrial fibrillation

Results from the RecordAF registry (REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation), presented today at the Scientific Sessions of the American Heart Association, show that in recently diagnosed and actively treated patients with atrial fibrillation (AF), a rhythm-control strategy provides better short term control of the arrhythmia versus a rate-control strategy but does not translate into a reduction in the occurrence of clinical events at 1 year.

16 Nov 2009

Ginger effective in treating post-chemo nausea in cancer patients

Reed's, Inc., maker of the top-selling sodas in natural food stores nationwide, announced today that it will be exhibiting at the Chemotherapy Foundation Symposium XXVII New Perspectives in Oncology Practice Seminar, Saturday November 14th, at the Marriott Marquis in New York, NY.

16 Nov 2009

Scientists find link between Alzheimer's disease and chronic heart failure

A team of U.S., Canadian and Italian scientists led by researchers at Johns Hopkins report evidence from studies in animals and humans supporting a link between Alzheimer's disease and chronic heart failure, two of the 10 leading causes of death in the United States.

16 Nov 2009

New shunt procedure may save infants with underdeveloped heart

Infants born with a severely underdeveloped heart are more likely to survive to their first birthday when treated with a new shunt procedure - yet it may not be the safest surgery long term, according to research presented at the American Heart Association's Scientific Sessions 2009.

16 Nov 2009

Aspirin doses have beneficial effects for patients with heart diorders: Study

On Sunday, November 15, 2009, Florida Atlantic University (FAU) researcher Charles H. Hennekens, M.D., the first Sir Richard Doll Research Professor in the Charles E. Schmidt College of Biomedical Science will present at the American Heart Association's Annual Scientific Sessions meeting in Orlando, FL, the first data in humans to show that all doses of aspirin used in clinical practice increase nitric oxide.

16 Nov 2009

Links present between Alzheimer's disease and chronic heart failure, support researchers

16 Nov 2009

Proteo's Elafin recommended for orphan drug status in Europe

The Committee for Orphan Medical Products (COMP) of the European Medicines Agency (EMEA) has issued a recommendation granting orphan drug status to Proteo's drug candidate Elafin for the treatment of esophagus carcinoma. The orphan drug status will become effective upon ratification of this recommendation by the European Commission.

16 Nov 2009

UT physicians treat Iraqi girl with myasthenia gravis

Plagued by a growing weakness that left her unable to walk, talk and even take a normal breath, 11-year-old Iraqi Aram Ali was a shell of the bright little girl she used to be.

16 Nov 2009

Normal synaptic activity in nerve cells protects brain from Huntington's disease

Investigators at Burnham Institute for Medical Research (Burnham), the University of British Columbia's Centre for Molecular Medicine and Therapeutics and the University of California, San Diego have found that normal synaptic activity in nerve cells (the electrical activity in the brain that allows nerve cells to communicate with one another) protects the brain from the misfolded proteins associated with Huntington's disease.

16 Nov 2009

Personal CGM improves glucose control for diabetes patients

In acknowledgement of this year’s World Diabetes Day, which calls on all those responsible for diabetes care to understand diabetes and take control, Medtronic, Inc. (NYSE: MDT) highlights the growing body of clinical evidence for Personal Continuous Glucose Monitoring (CGM) in improving glucose control for diabetes patients.

16 Nov 2009

Just one test not enough to detect heart defects in young athletes

To best detect early signs of life-threatening heart defects in young athletes, screening programs should include both popular diagnostic tests, not just one of them, according to new research from heart experts at Johns Hopkins.

16 Nov 2009

New technique to cool the brains of cardiac arrest patients

The first randomized intra-arrest cooling study performed using a novel intra-nasal cooling method showed much faster and earlier cooling in treated patients and significantly higher neurologically intact survival - to - discharge rate in many patients. The Pre-Resuscitation Intra-Nasal Cooling Effectiveness (PRINCE) study involved 200 patients and was conducted by 15 Emergency Medical Systems (EMS) in Belgium, Germany, Italy, Czech Republic and Sweden.

16 Nov 2009

Study finds striking similarities in people with schizophrenia across 37 different countries

An international study of more than 17,000 people with schizophrenia has found striking similarities in symptoms, medication, employment and sexual problems, despite the fact that it covered a diverse range of patients and healthcare systems in 37 different countries.

16 Nov 2009

New reversible oral anti-platelet medication had fewer cardiac events in heart attack patients

Acutely ill heart attack patients who received both aspirin and a new reversible oral anti-platelet medication had fewer cardiac events than patients on aspirin and the most commonly used, irreversible anti-platelet drug, researchers reported in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009.

16 Nov 2009

Medical Condition News

Transcendental Meditation lowers rates of heart attack, stroke, and death

Fetal exposure to phthalates has the potential to alter masculine brain development: Study

RecordAF presents results of recently diagnosed and treated patients with atrial fibrillation

Ginger effective in treating post-chemo nausea in cancer patients

Scientists find link between Alzheimer's disease and chronic heart failure

New shunt procedure may save infants with underdeveloped heart

Aspirin doses have beneficial effects for patients with heart diorders: Study

Links present between Alzheimer's disease and chronic heart failure, support researchers

Proteo's Elafin recommended for orphan drug status in Europe

UT physicians treat Iraqi girl with myasthenia gravis

Normal synaptic activity in nerve cells protects brain from Huntington's disease

Personal CGM improves glucose control for diabetes patients

Just one test not enough to detect heart defects in young athletes

New technique to cool the brains of cardiac arrest patients

Study finds striking similarities in people with schizophrenia across 37 different countries

New reversible oral anti-platelet medication had fewer cardiac events in heart attack patients

Chronic pain patients with depression three times more likely to receive opioid medications

Effects of vitamin D deficiency amplified by lower levels of sex hormone estrogen

Columbia University Medical Center presents the 2009 Naomi Berrie Awards

Merck to market and develop cardiovascular medicines for a range of cardiovascular disorders

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News